Who owns the COLLANEX trademark?

The COLLANEX trademark is owned by Stratus Pharmaceuticals, Inc..

What class is the COLLANEX trademark registered in?

The COLLANEX trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for COLLANEX?

The USPTO serial number for COLLANEX is 90654047.

What is the registration number for COLLANEX?

COLLANEX is registered under USPTO registration number 6981434.

Sealvo

Home Search: COLLANEXCOLLANEX #90654047

Back

Updated Sep 18, 2026·18 searches this week

View on USPTO TSDR Find similar marks

COL

USPTO Trademark Record

REGISTERED

COLLANEX

SN 90654047·Reg 6981434·Filed Apr 19, 2021

Owner Stratus Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

COLLANEX (Serial No. 90654047), Registration No. 6981434, is a registered US trademark filed on Apr 19, 2021 by Stratus Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: February 14, 2029

Conflict Analysis

Full conflict analysis for COLLANEX (SN 90654047) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

COLLANEX (Reg. #6981434) is a registered US trademark that has been protecting its owner, Stratus Pharmaceuticals, Inc., since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 19, 2021

SERIAL

90654047

REG#

6981434

REGISTERED

Feb 14, 2023

Filing Information

StatusREGISTERED

Filing DateApr 19, 2021

Serial Number90654047

Registration No.6981434

Registration DateFeb 14, 2023

Status DateFeb 14, 2023

Published for OppositionJan 25, 2022

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jan 01, 2022

First use in commerce: Jan 01, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

34 events

REGISTERED-PRINCIPAL REGISTER

Feb 14, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 14, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 11, 2023

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 10, 2023

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 15, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 15, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 15, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

SU - NON-FINAL ACTION - WRITTEN

Dec 14, 2022

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Dec 14, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 14, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Dec 09, 2022

STATEMENT OF USE PROCESSING COMPLETE

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 06, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

TEAS STATEMENT OF USE RECEIVED

Dec 06, 2022

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Dec 06, 2022

USE AMENDMENT FILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 05, 2022

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 1 GRANTED

Dec 05, 2022

SOU EXTENSION 1 GRANTED

NOTICE OF REVIVAL - E-MAILED

Oct 28, 2022

NOTICE OF REVIVAL - E-MAILED

SOU EXTENSION RECEIVED WITH TEAS PETITION

Oct 28, 2022

SOU EXTENSION RECEIVED WITH TEAS PETITION

PETITION TO REVIVE-GRANTED

Oct 28, 2022

PETITION TO REVIVE-GRANTED

TEAS PETITION TO REVIVE RECEIVED

Oct 28, 2022

TEAS PETITION TO REVIVE RECEIVED

ABANDONMENT - NO USE STATEMENT FILED

Oct 24, 2022

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Oct 24, 2022

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

SOU EXTENSION 1 FILED

Sep 22, 2022

SOU EXTENSION 1 FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 22, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jan 25, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 25, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 05, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 21, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Dec 14, 2021

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Dec 14, 2021

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Dec 14, 2021

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Dec 14, 2021

EXAMINER'S AMENDMENT ENTERED

ASSIGNED TO EXAMINER

Dec 13, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 26, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by Stratus Pharmaceuticals, Inc.

Additional USPTO filings from the same owner.

STR

STRATUS PHARMACEUTICALS

99423228

Stratus Pharmaceuticals, Inc.

REGISTERED

PEV

PEVIDERM

97846559

Stratus Pharmaceuticals, Inc.

REGISTERED

AZO

AZOLEN

98513961

Stratus Pharmaceuticals, Inc.

REGISTERED

SON

SONAFINE

98514002

Stratus Pharmaceuticals, Inc.

REGISTERED

Other Marks by Xavier Suarez

Additional USPTO filings handled by the same attorney of record.

ARC

ARCTIC RELIEF

90631616

REGISTERED

SOS

90715920

ABANDONED

COLLANEX

Run a conflict check

Other Marks by Stratus Pharmaceuticals, Inc.

Other Marks by Xavier Suarez

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company